Patent · US Active

Method for temporarily interrupting an extracorporeal blood treatment, control device and blood treatment apparatus

US9713670B2 · kind B2 · utility

1Cited by

1References

13Claims

0Family size

Assignee

Fresenius Medical Care Deutschland GmbH · DE

Inventors

Uwe Herrmann · Bernried, DE
Sabine Kipp · Bad Homburg vor der Höhe, DE
Christine Nachbaur-Sturm · Eitorf, DE
Thomas Pusinelli · Schongau, DE
Martin Gruendken · Rosbach, DE
Georg Verch · Wiesbaden, DE

Key dates

Filing date	Nov 23, 2010
Grant date	Jul 25, 2017
Priority date	—
Expiry date	Jun 29, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T137/0324
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A method for temporarily interrupting an extracorporeal treatment of blood of a patient by use of a blood treatment apparatus includes activating or controlling a control device which is provided and configured to bring the blood treatment apparatus into a state in which the blood treatment session of the patient can be interrupted with the intention to continue the blood treatment session. The present invention further provides a control device, a blood treatment apparatus, a digital storage means, a computer program product as well as a computer program.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.